About
HC Biologics is a global biotechnology and medical device company based in Miami, Florida. The company specializes in the development, manufacturing, and distribution of advanced biologics and orthopedic solutions aimed at enhancing patient outcomes and supporting healthcare professionals around the world. Their product portfolio includes advanced tissue-based medical products and allografts for various surgical applications, a comprehensive range of spinal products, and custom orthopedic implants produced using 3-D printing technology. HC Biologics also offers solutions for arthroplasty, trauma, arthroscopy, and cardiothoracic applications, showcasing a wide array of surgical and medical device solutions. With branch offices in multiple countries, including Mexico, Colombia, and the Netherlands, HC Biologics serves a diverse global customer base. The company is committed to quality and regulatory compliance, holding several certifications such as ISO 9001 and ISO 13485. Led by CEO Husnu Ceylan and Director of Global Sales Gabriela Prado, HC Biologics focuses on innovation and global expansion in the healthcare sector.
Technologies
Keywords
Company Information
-
Employees 34
-
Founded 2015
Location
1221 Brickell Ave, Miami, Florida, United States, 33131